Principal Financial Group Inc. decreased its stake in Chemours Company (The) (NYSE:CC) by 0.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 793,096 shares of the specialty chemicals company’s stock after selling 1,496 shares during the quarter. Principal Financial Group Inc. owned approximately 0.43% of Chemours Company (The) worth $40,139,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Koch Industries Inc. purchased a new stake in Chemours Company (The) in the second quarter worth about $704,000. Public Employees Retirement System of Ohio increased its position in Chemours Company (The) by 306.4% in the second quarter. Public Employees Retirement System of Ohio now owns 98,590 shares of the specialty chemicals company’s stock worth $3,739,000 after buying an additional 74,329 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. increased its position in Chemours Company (The) by 264.7% in the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 42,669 shares of the specialty chemicals company’s stock worth $1,618,000 after buying an additional 30,970 shares in the last quarter. Victory Capital Management Inc. increased its position in Chemours Company (The) by 292.0% in the second quarter. Victory Capital Management Inc. now owns 657,810 shares of the specialty chemicals company’s stock worth $24,944,000 after buying an additional 489,990 shares in the last quarter. Finally, Virginia Retirement Systems ET AL purchased a new stake in Chemours Company (The) in the second quarter worth about $1,460,000. Institutional investors and hedge funds own 72.90% of the company’s stock.

Chemours Company (CC) opened at $49.65 on Thursday. The firm has a market capitalization of $9,369.25, a PE ratio of 17.94, a PEG ratio of 0.88 and a beta of 3.59. The company has a debt-to-equity ratio of 5.07, a current ratio of 2.19 and a quick ratio of 1.63. Chemours Company has a one year low of $20.76 and a one year high of $58.08.

Chemours Company (The) (NYSE:CC) last released its quarterly earnings data on Thursday, November 2nd. The specialty chemicals company reported $1.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.01 by $0.11. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. Chemours Company (The) had a return on equity of 116.80% and a net margin of 4.86%. The business’s quarterly revenue was up 13.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.61 earnings per share. research analysts forecast that Chemours Company will post 3.73 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, December 15th. Investors of record on Monday, November 20th will be paid a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.24%. The ex-dividend date of this dividend is Friday, November 17th. Chemours Company (The)’s payout ratio is presently 8.28%.

A number of analysts have commented on CC shares. Citigroup Inc. upped their price target on Chemours Company (The) from $45.00 to $59.00 and gave the stock a “buy” rating in a research report on Friday, August 4th. Zacks Investment Research cut Chemours Company (The) from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 18th. UBS AG upped their price objective on Chemours Company (The) from $50.00 to $59.00 and gave the stock a “neutral” rating in a research note on Friday, November 3rd. J P Morgan Chase & Co upped their price objective on Chemours Company (The) to $55.00 and gave the stock an “overweight” rating in a research note on Friday, August 4th. Finally, Jefferies Group LLC upped their price objective on Chemours Company (The) to $60.00 and gave the stock a “buy” rating in a research note on Thursday, August 3rd. One research analyst has rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $53.89.

ILLEGAL ACTIVITY WARNING: “Principal Financial Group Inc. Has $40.14 Million Holdings in Chemours Company (The) (CC)” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2017/11/16/principal-financial-group-inc-has-40-14-million-holdings-in-chemours-company-the-cc.html.

In related news, SVP David C. Shelton sold 5,908 shares of the stock in a transaction that occurred on Friday, October 13th. The stock was sold at an average price of $56.01, for a total transaction of $330,907.08. Following the completion of the transaction, the senior vice president now directly owns 47,356 shares of the company’s stock, valued at $2,652,409.56. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP David C. Shelton sold 13,337 shares of the stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $48.48, for a total value of $646,577.76. The disclosure for this sale can be found here. Over the last three months, insiders have sold 76,520 shares of company stock valued at $4,008,293. 1.14% of the stock is owned by corporate insiders.

About Chemours Company (The)

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins.

Institutional Ownership by Quarter for Chemours Company (The) (NYSE:CC)

Receive News & Stock Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related stocks with our FREE daily email newsletter.